Forrest plots of the studies that evaluated the hazard ratios of high miR-155 expression vs. low expression.

<p>(A) Forrest plots of the included studies that evaluated the hazard ratios of high miR-155 expression vs. low expression. HR (95% CI) with adenocarcinoma, squamous cell carcinoma (Tom Donnem) and in Maryland, Norway, Japan (Motonobu Saito) in turn. (B) Forrest plots of the survival data reported as cancer-specific survival (CSS). (C) Forrest plots of the survival data reported as overall survival (OS). (D) Forrest plots of the survival data reported as disease-free survival (DFS) and relapse-free survival (RFS). (E) Forrest plots of the survival data from Asia. (F) Forrest plots of the survival data from the Americas. (G) Forrest plots of the survival data from Europe.